CXCR3 antagonists (Sanofi)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameCXCR3 antagonists (Sanofi)
Drug Alias Namebeta amino acid derivatives (Sanofi)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 3 antagonists
TargetsC-X-C motif chemokine receptor 3
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A